Bio Details

Karen A. Flynn has served as a member of our board since November 2023. Ms. Flynn retired in September 2022 from her position as Senior Vice President and Chief Commercial Officer at Catalent Pharma Solutions. She joined Catalent as President, Biologics and Chief Commercial Officer in 2020. Before Catalent, Ms. Flynn was Senior Vice President and Chief Commercial Officer for West Pharmaceutical Services, Inc. from 2016 to 2019, and served as its President of Pharmaceutical Packaging Systems from 2014. Ms. Flynn is a director on the board of Catalent and serves on the board of Quanterix Corporation. Previously she was a member of the board of directors of Recro Pharmaceuticals. She serves on the Board of Trustees for The Franklin Institute, with the University of Notre Dame’s Hesburgh Women of Impact mentorship program and also has been on the Chester County Economic Development Council Board of Directors and the Downingtown STEM Academy Advisory Board. Ms. Flynn holds a Master of Science in Business Administration from Boston University and a Master of Science in Engineering from the University of Pennsylvania. She received her Bachelor of Science in Pre-Professional Studies from the University of Notre Dame.